BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38623918)

  • 1. MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine.
    Ministrini S; Padro T
    Eur J Clin Invest; 2024 Jul; 54(7):e14223. PubMed ID: 38623918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics of Early Cardiometabolic Disease: Mechanisms and Precision Medicine.
    Baccarelli AA; Ordovás J
    Circ Res; 2023 Jun; 132(12):1648-1662. PubMed ID: 37289899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian system microRNAs - Role in the development of cardiovascular diseases.
    Škrlec I
    Adv Protein Chem Struct Biol; 2023; 137():225-267. PubMed ID: 37709378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Genomic Drivers of Adipose Distribution and Related Cardiometabolic Disorders: Opportunities for Precision Medicine.
    Lumish HS; O'Reilly M; Reilly MP
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):45-60. PubMed ID: 31747800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gender medicine. Sex- and gender-specific aspects of clinical medicine].
    Kautzky-Willer A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1022-30. PubMed ID: 25030232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Role of Precision Medicine in Cardiovascular Disease.
    Leopold JA; Loscalzo J
    Circ Res; 2018 Apr; 122(9):1302-1315. PubMed ID: 29700074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics and microRNAs in cardiovascular diseases.
    Colpaert RMW; Calore M
    Genomics; 2021 Mar; 113(2):540-551. PubMed ID: 33482325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine for cardiometabolic disease: a framework for clinical translation.
    Franks PW; Cefalu WT; Dennis J; Florez JC; Mathieu C; Morton RW; Ridderstråle M; Sillesen HH; Stehouwer CDA
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):822-835. PubMed ID: 37804856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries.
    Misra S; Aguilar-Salinas CA; Chikowore T; Konradsen F; Ma RCW; Mbau L; Mohan V; Morton RW; Nyirenda MJ; Tapela N; Franks PW
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):836-847. PubMed ID: 37804857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex and gender: modifiers of health, disease, and medicine.
    Mauvais-Jarvis F; Bairey Merz N; Barnes PJ; Brinton RD; Carrero JJ; DeMeo DL; De Vries GJ; Epperson CN; Govindan R; Klein SL; Lonardo A; Maki PM; McCullough LD; Regitz-Zagrosek V; Regensteiner JG; Rubin JB; Sandberg K; Suzuki A
    Lancet; 2020 Aug; 396(10250):565-582. PubMed ID: 32828189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early nutrition, epigenetics, and cardiovascular disease.
    Loche E; Ozanne SE
    Curr Opin Lipidol; 2016 Oct; 27(5):449-58. PubMed ID: 27495135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders.
    Campolo F; Catanzaro G; Venneri MA; Ferretti E; Besharat ZM
    Theranostics; 2022; 12(6):2631-2634. PubMed ID: 35401814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of epigenetics on cardiovascular disease.
    Prasher D; Greenway SC; Singh RB
    Biochem Cell Biol; 2020 Feb; 98(1):12-22. PubMed ID: 31112654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Medicine and Personalized Medicine in Cardiovascular Disease.
    Currie G; Delles C
    Adv Exp Med Biol; 2018; 1065():589-605. PubMed ID: 30051409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-biased gene and microRNA expression in the developing mouse brain is associated with neurodevelopmental functions and neurological phenotypes.
    Szakats S; McAtamney A; Cross H; Wilson MJ
    Biol Sex Differ; 2023 Sep; 14(1):57. PubMed ID: 37679839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases.
    Napoli C; Coscioni E; de Nigris F; Donatelli F
    Curr Opin Cardiol; 2021 May; 36(3):295-300. PubMed ID: 33605616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside.
    Sarno F; Benincasa G; List M; Barabasi AL; Baumbach J; Ciardiello F; Filetti S; Glass K; Loscalzo J; Marchese C; Maron BA; Paci P; Parini P; Petrillo E; Silverman EK; Verrienti A; Altucci L; Napoli C;
    Clin Epigenetics; 2021 Mar; 13(1):66. PubMed ID: 33785068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Treatment of Asthma: The Importance of Sex and Gender Differences.
    Jenkins CR; Boulet LP; Lavoie KL; Raherison-Semjen C; Singh D
    J Allergy Clin Immunol Pract; 2022 Apr; 10(4):963-971.e3. PubMed ID: 35150902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized lifestyle medicine: relevance for nutrition and lifestyle recommendations.
    Minich DM; Bland JS
    ScientificWorldJournal; 2013; 2013():129841. PubMed ID: 23878520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.